| Dr Danny Paul Smith, DO | |
|
7105 Nw 70th Ave, Johnston, IA 50131-1824 | |
| (515) 252-4317 | |
| Not Available |
| Full Name | Dr Danny Paul Smith |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 7105 Nw 70th Ave, Johnston, Iowa |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073738902 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 02300 (Iowa) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Danny Paul Smith, DO 3313 Sw 29th St, Ankeny, IA 50023-8878 Ph: (515) 965-9775 | Dr Danny Paul Smith, DO 7105 Nw 70th Ave, Johnston, IA 50131-1824 Ph: (515) 252-4317 |
News Archive
A new study from City, University of London suggests that effective communication from eye health professionals may help reduce patient fears after they are diagnosed with the 'dry' form of age-related macular degeneration
The U.S. Drug Enforcement Administration (DEA) had to resort to its emergency powers this Wednesday to ban K2 and other "fake pot" products that mimic the effects of marijuana. As of now it is illegal to possess or sell the five chemicals used to make the products for at least one year. The agency and the Department of Health and Human Services will further debate whether the chemicals should be permanently added to the federal list of controlled substances considered unsafe, highly abused and without medical use.
Clinical Data, Inc. today announced that it has raised gross proceeds of approximately $47.4 million through the public offering of 2,750,000 newly issued shares of its common stock at a price of $17.25 per share. All of the shares are being offered by Clinical Data, Inc.
Esperion Therapeutics, a privately held biotechnology company working to discover, develop and commercialize treatments for cardiovascular and metabolic diseases, today announced that the company has initiated a Phase I clinical study for ETC-1002, the company's novel small molecule compound designed to beneficially regulate the levels of plasma lipids and lipoproteins.
› Verified 3 days ago
Dr. Abbie D Ruisch, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5501 Nw 86th St, Suite 300, Johnston, IA 50131 Phone: 515-875-9035 Fax: 515-875-9036 | |
Carlos Alarcon-schroder, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5615 Nw 86th St, Johnston, IA 50131 Phone: 515-643-6000 Fax: 515-643-6001 | |
Amy Fulton, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5615 Nw 86th St, Johnston, IA 50131 Phone: 515-643-6000 Fax: 515-643-6001 | |
Jaspreet Singh, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5615 Nw 86th St, Johnston, IA 50131 Phone: 515-643-6000 Fax: 515-643-6001 | |
Thomas Charles Evans, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 7005 Nw Beaver Dr, Johnston, IA 50131 Phone: 515-270-6287 | |
Lindsey Hohulin, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 5501 Nw 86th St Ste 300, Johnston, IA 50131 Phone: 515-875-9035 Fax: 515-875-9036 |